🇺🇸 FDA
Pipeline program

Hypofractionated radiation/chemotherapy

NorthChinaPBGH

Phase 2 other completed

Quick answer

Hypofractionated radiation/chemotherapy for Non-small Cell Lung Cancer is a Phase 2 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Non-small Cell Lung Cancer
Phase
Phase 2
Modality
other
Status
completed

Clinical trials